Industry reports
Editor highlights

The Indian Pharmaceutical Industry 2013 Coming of Age in a Global Market

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug | Countries: Germany, India, Argentina, Brazil, Canada, Slovenia, Poland, Austria

Increasing Share of Indian Generics in the Global Pharmaceutical Market

Increasing Share of Indian Generics in the Global Pharmaceutical Market

  • $ 250
  • Industry report
  • by Gyan Research and Analytics Pvt. Ltd.
  • July 2013
  • 25 pages

Over the last two decades, India has gradually evolved into an influential player in the global pharmaceutical market. The country's pharmaceutical industry is estimated as the third-largest in the world in terms of volume and at USD X billion it was ranked 13th in terms of value in 2012. The Indian ...

Industries: Generic Drug | Countries: India

Pharma Wholesale and Distribution Market: World Outlook 2013-2023

Pharma Wholesale and Distribution Market: World Outlook 2013-2023

  • $ 2 621
  • Industry report
  • by Visiongain
  • June 2013
  • 203 pages

Report Details Discover trends and revenue potential in distributing and wholesaling of medicines Where's the drug wholesaling and distribution market heading? Visiongain's updated report predicts revenues there from 2013 to 2023. It also explains trends in business and technology, prospects, and opportunities ...

Industries: Generic Drug | Countries: World, China, Europe, United States, Japan, India, Brazil, Russian Federation, France, United Kingdom, Spain, Italy, Germany, Asia

The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market

The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market

  • $ 1 566
  • Industry report
  • by Espicom Business Intelligence
  • January 2013
  • 164 pages

The 20 companies examined in this report had combined sales of more than US$17.4 billion in their most recently reported fiscal year, which generally concluded on 31st March 2012. Ranbaxy reported revenue of Rs.99,769 million (US$2,145 million) for the calendar year ended 31st December 2011, making it ...

Industries: Generic Drug | Countries: India

Global Biosimilars Market - Products, Applications and Regulations

Global Biosimilars Market - Products, Applications and Regulations

  • $ 4 320
  • Industry report
  • by Industry Experts
  • November 2012
  • 354 pages

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies' position is expected to be challenged over the next ten years, since the rapid growth forecast for the ...

Industries: Generic Drug | Countries: World, Europe, United States, United Kingdom, Germany, France, Spain, Italy, India, South Korea

Intas: Biosimilars Company Analysis

Intas: Biosimilars Company Analysis

  • $ 3 800
  • Company report
  • by Datamonitor
  • July 2012
  • 41 pages

This analysis evaluates the company's strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company's biosimilars portfolio, including analysis of key product profiles, examining key drivers and resistors to development, market sizing, specifics of development ...

Industries: Generic Drug | Countries: India

Zydus Cadila: Biosimilars Company Analysis

Zydus Cadila: Biosimilars Company Analysis

  • $ 3 800
  • Company report
  • by Datamonitor
  • July 2012
  • 44 pages

This analysis evaluates the company's strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company's biosimilars portfolio, including analysis of key product profiles, examining key drivers and resistors to development, market sizing, specifics of development ...

Industries: Generic Drug | Countries: India

Dr. Reddy%s: Biosimilars Company Analysis

Dr. Reddy%s: Biosimilars Company Analysis

  • $ 3 800
  • Company report
  • by Datamonitor
  • July 2012
  • 36 pages

This analysis evaluates the company's strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company's biosimilars portfolio, including analysis of key product profiles, examining key drivers and resistors to development, market sizing, specifics of development ...

Industries: Generic Drug | Countries: India

Biocon: Biosimilars Company Analysis

Biocon: Biosimilars Company Analysis

  • $ 3 800
  • Company report
  • by Datamonitor
  • July 2012
  • 41 pages

This analysis evaluates the company's strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company's biosimilars portfolio, including analysis of key product profiles, examining key drivers and resistors to development, market sizing, specifics of development ...

Industries: Generic Drug | Countries: India

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

  • $ 3 500
  • Industry report
  • by GBI Research
  • June 2012
  • 88 pages

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Biosimilars in Emerging Economies ...

Industries: Generic Drug | Countries: China, India

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.